Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India.
Department of Radiation Oncology, Amrita Vishwa Vidyapeetham, Kochi, India.
J Oncol Pharm Pract. 2021 Jul;27(5):1061-1072. doi: 10.1177/10781552211011539. Epub 2021 May 4.
Radiations dissipated are high energy waves used mostly as treatment intervention in controlling the unwanted multiplication of cell. About 60%-65% of cancer treatment requires radiation therapy and 40%-80% of radiation therapy causes RINV which are true troublemakers. Radiation therapy (RT) is targeted therapy mostly used to treat early stages of tumour and prevent their reoccurrence. They mainly destroy the genetic material (DNA) of cancerous cells to avoid their unwanted growth and division. The RINV affects the management and quality of life of patients which further reduces the patient outcome. RINV depends on RT related factors (dose, fractionation, irradiation volume, RT techniques) and patient related factors like (gender, health conditions, age, concurrent chemotherapy, psychological state, and tumour stage). RT is an active area of research and there is only limited progress in tackling the RINV crisis. Advanced technological methods are adopted that led to better understanding of total lethal doses. Radiation therapy also affects the immunity system that leads to radiation induced immune responses and inflammation. Radio sensitizers are used to sensitize the tumour cells to radiations that further prevent the normal cell damage from radiation exposure. There is a need for future studies and researches to re-evaluate the data available from previous trials in RINV to make better effective antiemetic regimen. The article focuses on radiation therapy induced nausea and vomiting along with their mechanism of action and treatment strategies in order to have a remarkable patient care.
辐射散逸是一种高能波,主要用于控制细胞的异常增殖,作为治疗干预手段。大约 60%-65%的癌症治疗需要放射治疗,而 40%-80%的放射治疗会导致 RINV,这是真正的麻烦制造者。放射治疗(RT)是一种靶向治疗,主要用于治疗肿瘤的早期阶段,以防止其复发。它们主要破坏癌细胞的遗传物质(DNA),以避免其不受控制的生长和分裂。RINV 会影响患者的管理和生活质量,从而进一步降低患者的预后。RINV 取决于与 RT 相关的因素(剂量、分割、照射体积、RT 技术)和与患者相关的因素,如(性别、健康状况、年龄、同期化疗、心理状态和肿瘤分期)。RT 是一个活跃的研究领域,在解决 RINV 危机方面只有有限的进展。采用了先进的技术方法,从而更好地了解总致死剂量。放射治疗还会影响免疫系统,导致辐射诱导的免疫反应和炎症。辐射增敏剂被用于使肿瘤细胞对辐射敏感,从而进一步防止正常细胞因辐射暴露而受损。需要进行未来的研究和调查,重新评估 RINV 中以前试验的现有数据,以制定更好的有效的止吐方案。本文重点介绍放射治疗引起的恶心和呕吐及其作用机制和治疗策略,以便为患者提供更好的护理。